KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Non-Current Assets (2016 - 2025)

Historic Non-Current Assets for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $60.6 billion.

  • Bristol Myers Squibb's Non-Current Assets fell 346.21% to $60.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $245.0 billion, marking a year-over-year decrease of 807.81%. This contributed to the annual value of $60.6 billion for FY2025, which is 346.21% down from last year.
  • Latest data reveals that Bristol Myers Squibb reported Non-Current Assets of $60.6 billion as of Q4 2025, which was down 346.21% from $61.3 billion recorded in Q3 2025.
  • Bristol Myers Squibb's 5-year Non-Current Assets high stood at $85.3 billion for Q1 2021, and its period low was $60.6 billion during Q4 2025.
  • In the last 5 years, Bristol Myers Squibb's Non-Current Assets had a median value of $67.5 billion in 2023 and averaged $68.9 billion.
  • In the last 5 years, Bristol Myers Squibb's Non-Current Assets plummeted by 1454.57% in 2022 and then surged by 471.31% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Non-Current Assets (Quarter) stood at $76.1 billion in 2021, then decreased by 8.55% to $69.5 billion in 2022, then fell by 8.85% to $63.4 billion in 2023, then fell by 0.89% to $62.8 billion in 2024, then decreased by 3.46% to $60.6 billion in 2025.
  • Its Non-Current Assets stands at $60.6 billion for Q4 2025, versus $61.3 billion for Q3 2025 and $61.5 billion for Q2 2025.